Upstream Bio, Inc. (UPB)
29.40
-1.40
(-4.53%)
USD |
NASDAQ |
Feb 04, 16:00
29.40
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio Market Cap : 1.585B for Feb. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 15.23M |
| AIM ImmunoTech, Inc. | 3.118M |
| IGC Pharma, Inc. | 23.69M |
| NovaBay Pharmaceuticals, Inc. | 119.87M |
| Protalix Biotherapeutics, Inc. | 232.82M |
Market Cap Related Metrics
| PS Ratio | 564.34 |
| Price to Book Value | 4.186 |
| Price | 29.40 |
| Earnings Yield | -7.77% |